The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2017 Apr 5

PMID 28375512

Citations 629

Authors

Latania K Logan

Robert A Weinstein

Affiliations

Soon will be listed here.

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are a serious public health threat. Infections due to these organisms are associated with significant morbidity and mortality. Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; β-lactamase genes carried on mobile genetic elements are a key mechanism for the rapid spread of antibiotic-resistant GNB worldwide. Transmissible carbapenem-resistance in Enterobacteriaceae has been recognized for the last 2 decades, but global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) is a more recent problem that, once initiated, has been occurring at an alarming pace. In this article, we discuss the evolution of CRE, with a focus on the epidemiology of the CPE pandemic; review risk factors for colonization and infection with the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae; and present strategies used to halt the striking spread of these deadly pathogens.

Citing Articles

Molecular epidemiology and patient outcome of carbapenem-resistant and in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network.

Saito S, Sakurai A, Matsumura Y, Uemura K, Hase R, Kato H JAC Antimicrob Resist. 2025; 7(2):dlaf027.

PMID: 40051884 PMC: 11882498. DOI: 10.1093/jacamr/dlaf027.

Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health.

Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G Antibiotics (Basel). 2025; 14(2).

PMID: 40001385 PMC: 11852015. DOI: 10.3390/antibiotics14020141.

Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria.

Mourabiti F, Jouga F, Sakoui S, El Hosayny O, Zouheir Y, Soukri A Arch Microbiol. 2025; 207(3):58.

PMID: 39948320 DOI: 10.1007/s00203-025-04252-z.

Genome drafting of nosocomial infection CRE confirming resistance to colistin and eravacycline, carrying , , and , in neonatology from November to December 2023.

Zhou X, Wagh K, Lv G, Sharma D, Lei W Front Cell Infect Microbiol. 2025; 14:1528017.

PMID: 39931631 PMC: 11807969. DOI: 10.3389/fcimb.2024.1528017.

Exploring New Delhi Metallo Beta Lactamases in Klebsiella pneumoniae and Escherichia coli: genotypic vs. phenotypic insights.

Ain N, Elton L, Sadouki Z, McHugh T, Riaz S Ann Clin Microbiol Antimicrob. 2025; 24(1):12.

PMID: 39923059 PMC: 11806598. DOI: 10.1186/s12941-025-00775-x.

References

Kaiser R, Castanheira M, Jones R, Tenover F, Lynfield R . Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2013; 76(3):356-60. DOI: 10.1016/j.diagmicrobio.2013.03.032. View

Jacoby G . AmpC beta-lactamases. Clin Microbiol Rev. 2009; 22(1):161-82, Table of Contents. PMC: 2620637. DOI: 10.1128/CMR.00036-08. View

Poirel L, Potron A, Nordmann P . OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012; 67(7):1597-606. DOI: 10.1093/jac/dks121. View

Vatopoulos A . High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. Euro Surveill. 2008; 13(4). View

Lin M, Lyles-Banks R, Lolans K, Hines D, Spear J, Petrak R . The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013; 57(9):1246-52. PMC: 8383150. DOI: 10.1093/cid/cit500. View

Siegel J, Rhinehart E, Jackson M, Chiarello L . Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007; 35(10 Suppl 2):S165-93. DOI: 10.1016/j.ajic.2007.10.006. View

Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

Logan L, Renschler J, Gandra S, Weinstein R, Laxminarayan R . Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis. 2015; 21(11):2014-21. PMC: 4622248. DOI: 10.3201/eid2111.150548. View

Castanheira M, Deshpande L, Mathai D, Bell J, Jones R, Mendes R . Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2010; 55(3):1274-8. PMC: 3067112. DOI: 10.1128/AAC.01497-10. View

10.

Pereira P, de Araujo C, Seki L, Zahner V, DAlincourt Carvalho-Assef A, Asensi M . Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother. 2012; 68(2):312-6. DOI: 10.1093/jac/dks396. View

11.

Ito H, Arakawa Y, Ohsuka S, Wacharotayankun R, Kato N, Ohta M . Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother. 1995; 39(4):824-9. PMC: 162636. DOI: 10.1128/AAC.39.4.824. View

12.

Gupta N, Limbago B, Patel J, Kallen A . Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011; 53(1):60-7. DOI: 10.1093/cid/cir202. View

13.

. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013; 62(9):165-70. PMC: 4604788. View

14.

Walsh T . Emerging carbapenemases: a global perspective. Int J Antimicrob Agents. 2010; 36 Suppl 3:S8-14. DOI: 10.1016/S0924-8579(10)70004-2. View

15.

Kitchel B, Rasheed J, Endimiani A, Hujer A, Anderson K, Bonomo R . Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2010; 54(10):4201-7. PMC: 2944623. DOI: 10.1128/AAC.00008-10. View

16.

Chiotos K, Han J, Tamma P . Carbapenem-Resistant Enterobacteriaceae Infections in Children. Curr Infect Dis Rep. 2015; 18(1):2. PMC: 4975038. DOI: 10.1007/s11908-015-0510-9. View

17.

Paterson D, Bonomo R . Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4):657-86. PMC: 1265908. DOI: 10.1128/CMR.18.4.657-686.2005. View

18.

Walsh T, Weeks J, Livermore D, Toleman M . Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011; 11(5):355-62. DOI: 10.1016/S1473-3099(11)70059-7. View

19.

Chen L, Mathema B, Pitout J, DeLeo F, Kreiswirth B . Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio. 2014; 5(3):e01355-14. PMC: 4073492. DOI: 10.1128/mBio.01355-14. View

20.

Logan L, Bonomo R . Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States Children. Open Forum Infect Dis. 2016; 3(2):ofw090. PMC: 4943557. DOI: 10.1093/ofid/ofw090. View